37 results
424B3
CTMX
CytomX Therapeutics Inc
25 Aug 23
Prospectus supplement
5:36pm
competitors, our industry, international conflict or uncertainties; and
the extent to which COVID-19 or any future pandemic and related governmental
8-K
EX-99.1
bs9o0nr
9 May 23
CytomX Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
4:12pm
8-K
EX-99.1
ka7vtp4wvgc
8 Nov 22
CytomX Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
4:09pm
8-K
EX-99.1
5ih kwdckicjr
4 Aug 22
CytomX Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
4:12pm
8-K
EX-99.1
26756r 71c
5 May 22
CytomX Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update
12:00am
424B5
uvnzstx77wgisr
4 Mar 22
Prospectus supplement for primary offering
5:22pm
8-K
EX-99.1
62ho3fblmkdj sncl0
10 Jan 22
Regulation FD Disclosure
8:00am
8-K
EX-99.1
2xcx0efn
4 Nov 21
CytomX Therapeutics Announces Third Quarter 2021 Financial Results
4:13pm